Literature DB >> 2825057

Antinociceptive activity induced by tizanidine and alpha 2-adrenoreceptors.

T Nabeshima1, K Matsuno, A Sugimoto, T Kameyama.   

Abstract

Tizanidine [5-chloro-4-(2-imidazolin-2-yl-amino)-2,1,3-benzothiadiazole] is able to increase the pain threshold in the tail-flick test in mice. The effect of tizanidine was investigated after treatment of mice with drugs influencing central monoaminergic and GABAergic mechanisms. A drug that inhibits the synthesis and storage of monoamines and drugs that cause specific lesions of monoaminergic neurons had no consistent effect on the antinociceptive action of tizanidine. The action of tizanidine was antagonized by the alpha 2-adrenoreceptor antagonist, yohimbine, but not by the alpha 1 antagonist prazosin, nor by dopamine, serotonin and GABA receptor antagonists. These results indicate that the antinociceptive action induced by tizanidine may be mediated by alpha 2-adrenoreceptors.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2825057     DOI: 10.1016/0028-3908(87)90162-6

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  4 in total

Review 1.  Muscle pain due to injury.

Authors:  A H Wheeler; G W Aaron
Journal:  Curr Pain Headache Rep       Date:  2001-10

2.  Antinociceptive effects of the stereoisomers of nicotine given intrathecally in spinal rats.

Authors:  M K Christensen; D F Smith
Journal:  J Neural Transm Gen Sect       Date:  1990

Review 3.  Tizanidine. A review of its pharmacology, clinical efficacy and tolerability in the management of spasticity associated with cerebral and spinal disorders.

Authors:  A J Wagstaff; H M Bryson
Journal:  Drugs       Date:  1997-03       Impact factor: 9.546

4.  Spinal antinociceptive action of amiloride and its interaction with tizanidine in the rat formalin test.

Authors:  Handong Ouyang; Peizong Wang; Wan Huang; Qiang Li; Bilin Nie; Weian Zeng
Journal:  Pain Res Manag       Date:  2015-09-10       Impact factor: 3.037

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.